HighTower Advisors »

Serina Therapeutics shares owned by HighTower Advisors

Quarter-by-quarter ownership of Serina Therapeutics (SER) shares owned by HighTower Advisors from 13F filings

Historical chart of HighTower Advisors investment in Serina Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Serina Therapeutics held by HighTower Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Serina Therapeutics by HighTower Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $215k 23k 9.56

More positions owned by HighTower Advisors

Apple (AAPL)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Amazon (AMZN)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Exxon Mobil Corporation (XOM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Johnson & Johnson (JNJ)

View all positions for HighTower Advisors

Top funds holding Serina Therapeutics

Broadwood Capital
Geode Capital Management
HighTower Advisors
Vanguard Group
Millennium Management
BlackRock
Tower Research Capital
Bank of America Corporation
Piscataqua Savings Bank
Riggs Asset Managment
Jpmorgan Chase & Co
Albion Financial Group
Pacifica Partners
Advisor Group Holdings
UBS Group

View all funds holding Serina Therapeutics